BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  Life Science Intelligence partners with Opus Origin to accelerate the expansion of its premium global platforms for medtech innovation and investment

  September 23, 2026

   · 

  1 min read
• 

  Venture capital

  AI drug hunter Enveda raises $311M for late-stage obesity, inflammatory disease push

  Tech darling Enveda has raised a total of $845 million in the past six years. The latest funding round is intended to pave the way for an IPO someday.

  September 23, 2026

   · 

  1 min read

   · 

  Annalee Armstrong
• Press Releases

  New model-based analysis further supports the potential of TECVAYLI®▼ (teclistamab) plus daratumumab to redefine long-term survival expectations in early line relapsed/refractory multiple myeloma

  September 23, 2026

   · 

  21 min read
• Press Releases

  New model-based analysis further supports the potential of TECVAYLI® (teclistamab-cqyv) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) to redefine long-term survival expectations in early line relapsed/refractory multiple myeloma

  September 23, 2026

   · 

  38 min read
• Press Releases

  Transcripta Bio Announces Scientific Advisory Board to Advance High-Certainty Drug Discovery

  September 23, 2026

   · 

  5 min read
• Press Releases

  Catalyst OrthoScience Joins Redefine Surgery as Founding Partner in Shoulder

  September 23, 2026

   · 

  4 min read
• 

  Immunology and inflammation

  Immunovant ditches lupus for multi-hyphenate inflammatory drug after mid-stage miss

  After imeroprubart failed to demonstrate sufficient efficacy in lupus during a Phase 2b trial, Immunovant is moving on from the indication and looking to other high priority programs for the drug in neurology, endocrinology and rheumatology.

  September 23, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements

  September 23, 2026

   · 

  5 min read
• Press Releases

  Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

  September 23, 2026

   · 

  6 min read
• Press Releases

  MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

  September 23, 2026

   · 

  6 min read